Finance

Lists
000597:SHE
Northeast Pharmaceutical Group Co Ltd
CNÂ¥4.76
+1.49%
(+0.070) 1D
Sep 30, 3:04:54 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000597...
Open
CNÂ¥4.70
High
CNÂ¥4.79
Low
CNÂ¥4.68
Mkt. cap
6.69B
Avg. vol.
20.40M
Volume
12.83M
Dividend
1.16%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 23, 2026
P/E ratio
32.09
52-wk high
CNÂ¥5.93
52-wk low
CNÂ¥4.09
EPS
CNÂ¥0.15
Shares outstanding
1.43B
No. of employees
6K
Open
CNÂ¥4.70
High
CNÂ¥4.79
Low
CNÂ¥4.68
Mkt. cap
6.69B
Avg. vol.
20.40M
Volume
12.83M
Dividend
1.16%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 23, 2026
P/E ratio
32.09
52-wk high
CNÂ¥5.93
52-wk low
CNÂ¥4.09
EPS
CNÂ¥0.15
Shares outstanding
1.43B
No. of employees
6K
News stories
From web sources and news partners
About Northeast Pharmaceutical Group Co Ltd
CEO-
Employees5.73K
Founded1946
Headquarters-
SectorPharmaceutical industry
Websitenepharm.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.63B
1.60B
2.01B
1.33B
Cost of goods sold
937.61M
1.09B
1.44B
816.84M
Cost of revenue
937.61M
1.09B
1.44B
816.84M
Research and development expenses
32.17M
68.30M
34.05M
33.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
478.03M
459.82M
415.94M
389.73M
Operating expense
459.45M
614.84M
472.18M
407.46M
Total operating expenses
1.40B
1.70B
1.91B
1.22B
Operating income
228.41M
-103.91M
98.38M
102.48M
Other non operating income
-22.46M
-899.20K
-24.34M
-3.50M
EBT including unusual items
62.18M
65.43M
28.13M
71.54M
EBT excluding unusual items
222.24M
-117.82M
77.81M
95.44M
Income tax expense
25.40M
8.65M
11.77M
24.10M
Effective tax rate
40.85%
13.22%
41.83%
33.69%
Other operating expenses
-48.82M
87.61M
19.91M
-13.79M
Net income
43.52M
87.37M
26.63M
57.23M
Net profit margin
2.68%
5.47%
1.33%
4.31%
Earnings per share
-
-
-
-
Interest and investment income
22.85M
26.26M
14.43M
10.65M
Interest expense
-11.66M
-13.43M
-10.65M
-14.18M
Net interest expenses
11.19M
12.83M
3.78M
-3.53M
Depreciation and amortization charges
-
-
-
-
EBITDA
364.09M
23.50M
225.79M
221.44M
Gain or loss from assets sale
181.51K
-255.86K
-
-413.49K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps